These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 29388173)

  • 41. Risperidone, olanzapine and quetiapine in the treatment of behavioral and psychological symptoms in patients with Alzheimer's disease: preliminary findings from a naturalistic, retrospective study.
    Rocca P; Marino F; Montemagni C; Perrone D; Bogetto F
    Psychiatry Clin Neurosci; 2007 Dec; 61(6):622-9. PubMed ID: 18081622
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Solitary living in Alzheimer's disease over 3 years: association between cognitive and functional impairment and community-based services.
    Wattmo C; Londos E; Minthon L
    Clin Interv Aging; 2014; 9():1951-62. PubMed ID: 25484578
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Factors affecting the appetites of persons with Alzheimer's disease and mild cognitive impairment.
    Suma S; Watanabe Y; Hirano H; Kimura A; Edahiro A; Awata S; Yamashita Y; Matsushita K; Arai H; Sakurai T
    Geriatr Gerontol Int; 2018 Aug; 18(8):1236-1243. PubMed ID: 29808955
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Determinants of quality of life in Alzheimer's disease: perspective of patients, informal caregivers, and professional caregivers.
    Gómez-Gallego M; Gómez-Amor J; Gómez-García J
    Int Psychogeriatr; 2012 Nov; 24(11):1805-15. PubMed ID: 22697366
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk of Mortality Associated with Antipsychotic Monotherapy and Polypharmacy Among Community-Dwelling Persons with Alzheimer's Disease.
    Koponen M; Taipale H; Lavikainen P; Tanskanen A; Tiihonen J; Tolppanen AM; Ahonen R; Hartikainen S
    J Alzheimers Dis; 2017; 56(1):107-118. PubMed ID: 27935554
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Efficacy of atypical antipsychotics in patients with Alzheimer's dementia. CATIE-AD-Study (Clinical Antipsychotic Trials of Intervention Effectiveness Alzheimer's Disease)].
    Förstl H
    Internist (Berl); 2007 Jun; 48(6):642-4. PubMed ID: 17497111
    [No Abstract]   [Full Text] [Related]  

  • 47. Anticholinergics and benzodiazepines on cognitive impairment among elderly with Alzheimer's disease: a 1 year follow-up study.
    Jenraumjit R; Chinwong S; Chinwong D; Kanjanarach T; Kshetradat T; Wongpakaran T; Wongpakaran N
    BMC Res Notes; 2020 Jan; 13(1):4. PubMed ID: 31898553
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mild versus moderate stages of Alzheimer's disease: three-year outcomes in a routine clinical setting of cholinesterase inhibitor therapy.
    Wattmo C; Minthon L; Wallin ÅK
    Alzheimers Res Ther; 2016 Feb; 8():7. PubMed ID: 26883213
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Olanzapine does not enhance cognition in non-agitated and non-psychotic patients with mild to moderate Alzheimer's dementia.
    Kennedy J; Deberdt W; Siegal A; Micca J; Degenhardt E; Ahl J; Meyers A; Kaiser C; Baker RW
    Int J Geriatr Psychiatry; 2005 Nov; 20(11):1020-7. PubMed ID: 16250069
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Participant-Informant Relationships Affect Quality of Life Ratings in Incipient and Clinical Alzheimer Disease.
    Lin A; Brook J; Grill JD; Teng E
    Am J Geriatr Psychiatry; 2017 Mar; 25(3):297-307. PubMed ID: 27818119
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Metabolic adverse effects of olanzapine on cognitive dysfunction: A possible relationship between BDNF and TNF-alpha.
    Zhang C; Fang X; Yao P; Mao Y; Cai J; Zhang Y; Chen M; Fan W; Tang W; Song L
    Psychoneuroendocrinology; 2017 Jul; 81():138-143. PubMed ID: 28477447
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High prevalence of psychotropic drug use among persons with and without Alzheimer's disease in Finnish nationwide cohort.
    Taipale H; Koponen M; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S
    Eur Neuropsychopharmacol; 2014 Nov; 24(11):1729-37. PubMed ID: 25453487
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fibre-specific white matter reductions in Alzheimer's disease and mild cognitive impairment.
    Mito R; Raffelt D; Dhollander T; Vaughan DN; Tournier JD; Salvado O; Brodtmann A; Rowe CC; Villemagne VL; Connelly A
    Brain; 2018 Mar; 141(3):888-902. PubMed ID: 29309541
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Responsiveness of the quality of life in late-stage dementia scale to psychotropic drug treatment in late-stage dementia.
    Martin-Cook K; Hynan LS; Rice-Koch K; Svetlik DA; Weiner MF
    Dement Geriatr Cogn Disord; 2005; 19(2-3):82-5. PubMed ID: 15572876
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of commonly prescribed drugs on cognition and mild cognitive impairment in healthy elderly people.
    Del Ser T; Zea MA; Valentí M; Olazarán J; López-Álvarez J; Rebollo-Vázquez A; Ávila-Villanueva M; Frades B; Medina M; Fernández-Blázquez MA
    J Psychopharmacol; 2019 Aug; 33(8):965-974. PubMed ID: 31241413
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A double-blind randomized placebo-controlled withdrawal trial comparing memantine and antipsychotics for the long-term treatment of function and neuropsychiatric symptoms in people with Alzheimer's disease (MAIN-AD).
    Ballard C; Thomas A; Gerry S; Yu LM; Aarsland D; Merritt C; Corbett A; Davison C; Sharma N; Khan Z; Creese B; Loughlin P; Bannister C; Burns A; Win SN; Walker Z;
    J Am Med Dir Assoc; 2015 Apr; 16(4):316-22. PubMed ID: 25523285
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Frequency and subgroups of neuropsychiatric symptoms in mild cognitive impairment and different stages of dementia in Alzheimer's disease.
    Siafarikas N; Selbaek G; Fladby T; Šaltytė Benth J; Auning E; Aarsland D
    Int Psychogeriatr; 2018 Jan; 30(1):103-113. PubMed ID: 28927477
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antipsychotic Use and the Risk of Hip Fracture Among Community-Dwelling Persons With Alzheimer's Disease.
    Koponen M; Taipale H; Lavikainen P; Tanskanen A; Tiihonen J; Tolppanen AM; Ahonen R; Hartikainen S
    J Clin Psychiatry; 2017 Mar; 78(3):e257-e263. PubMed ID: 28146612
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sociodemographic and clinical correlates of utility scores in Alzheimer's disease.
    Miller EA; Schneider LS; Zbrozek A; Rosenheck RA
    Value Health; 2008 Dec; 11(7):1120-30. PubMed ID: 18489496
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Risk of pneumonia associated with incident benzodiazepine use among community-dwelling adults with Alzheimer disease.
    Taipale H; Tolppanen AM; Koponen M; Tanskanen A; Lavikainen P; Sund R; Tiihonen J; Hartikainen S
    CMAJ; 2017 Apr; 189(14):E519-E529. PubMed ID: 28396328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.